Effectiveness of pamidronate in severe neonatal hypercalcemia caused by subcutaneous fat necrosis: a case report

Eur J Pediatr. 2009 May;168(5):625-7. doi: 10.1007/s00431-008-0797-8. Epub 2008 Aug 23.

Abstract

Subcutaneous fat necrosis of the newborn (SCFN) is a panniculitis that develops in fatty areas during the first weeks of life after foetal distress or perinatal complications. Prognosis is generally good with complete regression, but it can be complicated by metabolic abnormalities like hypoglycemia, hypertriglyceridemia, thrombocytopenia, and also potentially life-threatening hypercalcemia. We report a case of severe hypercalcemia complicating SCFN in a newborn who was treated with hyperhydration, furosemide, prednisone, and pamidronate.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Diphosphonates / therapeutic use*
  • Fat Necrosis / complications*
  • Fat Necrosis / pathology
  • Female
  • Humans
  • Hypercalcemia / drug therapy*
  • Hypercalcemia / etiology*
  • Pamidronate

Substances

  • Anti-Inflammatory Agents
  • Diphosphonates
  • Pamidronate